• Walker & Dunlop recently arranged a US$137.5 million, three-year floating-rate refinancing with AllianceBernstein for 12 Halsey, a newly completed Class A mixed-use multifamily property in Brooklyn’s Bedford-Stuyvesant, serving as exclusive advisor to developers EJS Group and Hope Street Capital.
• The transaction, which includes 240 residential units with 30% reserved as affordable housing under New York’s Affordable New York (421-a) program plus ground-floor retail, underscores Walker & Dunlop’s role in connecting institutional capital to projects that blend market-rate and affordable urban housing.
• We’ll now examine how securing this US$137.5 million refinancing for a mixed-income Brooklyn property influences Walker & Dunlop’s broader investment narrative.

AI is about to change healthcare. These 41 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

Walker & Dunlop Investment Narrative Recap

To own Walker & Dunlop, you need to believe in its ability to turn a larger multifamily and capital markets footprint into growing, fee-based revenues, despite recent earnings pressure and valuation concerns. The US$137.5 million 12 Halsey refinancing highlights activity in mixed-income multifamily, but does not materially change the key near term catalyst of a broader transaction recovery or the main risk from elevated interest rates and rate volatility.

Among recent announcements, the upcoming Q2 2026 earnings release on August 6, 2026 is the most relevant in this context, as it will show how transactions like 12 Halsey and other recent financings are flowing through to revenue, margins, and servicing growth. That update sits alongside longer term initiatives such as affordable housing expansion and capital markets hiring, which are central to whether Walker & Dunlop can justify its higher earnings multiple over time.

Yet while multifamily activity like 12 Halsey looks constructive, investors should be aware that elevated interest rates continue to...

Walker & Dunlop's narrative projects $1.7 billion revenue and $211.3 million earnings by 2029. This requires 11.8% yearly revenue growth and about a $143 million earnings increase from $68.3 million today.

Uncover how Walker & Dunlop's forecasts yield a $67.33 fair value, a 29% upside to its current price.

Exploring Other Perspectives

Three members of the Simply Wall St Community currently place fair value for Walker & Dunlop between US$31.95 and US$67.33, showing a wide range of expectations. Against that backdrop, the reliance on stronger transaction volumes and multifamily demand puts extra weight on how quickly capital actually moves back into commercial real estate, so it is worth reviewing several viewpoints before forming your own stance.

Explore 3 other fair value estimates on Walker & Dunlop - why the stock might be worth 39% less than the current price!

The Verdict Is Yours

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Walker & Dunlop research is our analysis highlighting 2 key rewards and 4 important warning signs that could impact your investment decision.
• Our free Walker & Dunlop research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Walker & Dunlop's overall financial health at a glance.

Ready For A Different Approach?

Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:

• Capitalize on the AI infrastructure supercycle with our selection of the 55 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
• Uncover the next big thing with 21 elite penny stocks that balance risk and reward.
• Find 53 companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.